Durable remission of folliculotropic mycosis fungoides achieved with a combined topical treatment with cytarabine and carmustine.
Folliculotropic mycosis fungoides (MF) is an uncommon subtype of MF which has a more aggressive natural history and is more resistant to treatment than other forms of MF. In this article, an innovative method of treatment is presented. We describe a successful use of topical cytarabine combined with topical carmustine in a patient with a folliculotropic MF. Based on our patient history we suggest this method as an effective therapy option for patients with folliculotropic MF unresponsive to other forms of treatment.
Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland.
Monika
M
Heisig
Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland.
Joanna
J
Maj
Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland.
Jacek C
JC
Szepietowski
Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland.
Adam
A
Reich
D000279:Administration, Cutaneous; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001706:Biopsy; D002330:Carmustine / Q000008:administration & dosage*; D003561:Cytarabine / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000188:drug therapy* / Q000473:pathology; D012074:Remission Induction; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D013997:Time Factors; D016896:Treatment Outcome
D003561:Cytarabine; D002330:Carmustine
cutaneous T cell lymphoma; dermatooncology; topical chemotherapy